Waterpipe smoking: a review of pulmonary and health effects.
Journal
European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
received:
25
11
2020
accepted:
27
01
2021
entrez:
13
5
2021
pubmed:
14
5
2021
medline:
25
11
2021
Statut:
epublish
Résumé
Waterpipe smoking is an old form of tobacco smoking, originating in Persia and the Middle East. The popularity of the waterpipe is increasing worldwide, particularly among young adults, and there are widespread misconceptions regarding its negative health effects. The inhaled smoke of the waterpipe contain several toxic and hazardous materials including nicotine, tar, polyaromatic hydrocarbons and heavy metals, all of which are proven to be related to lung diseases and cancer. Regular waterpipe smoking is associated with respiratory symptoms, a decrease in pulmonary function and increased risk for lung disease such as COPD. Additional negative health effects include increased risk for arterial stiffness, ischaemic heart disease and several cancer types including lung cancer. This review summarises the negative health effects of waterpipe smoking, with emphasis on cardiorespiratory complications. Increased awareness and knowledge amongst healthcare professionals will hopefully help identify waterpipe smokers and promote patient education. Applying World Health Organization (WHO) regulations will provide a synergistic effect in reducing waterpipe use and associated disease.
Identifiants
pubmed: 33980668
pii: 30/160/200374
doi: 10.1183/16000617.0374-2020
pmc: PMC9488736
pii:
doi:
Substances chimiques
Smoke
0
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright ©The authors 2021.
Déclaration de conflit d'intérêts
Conflict of interest: F. Darawshy has nothing to disclose. Conflict of interest: A. Abu Rmeileh has nothing to disclose. Conflict of interest: R. Kuint has nothing to disclose. Conflict of interest: N. Berkman has nothing to disclose.
Références
Food Chem Toxicol. 2008 May;46(5):1582-90
pubmed: 18308445
Int J Occup Med Environ Health. 2017 Jul 14;30(5):731-742
pubmed: 29093578
Respir Med. 2014 Sep;108(9):1241-53
pubmed: 25130679
Fam Pract. 2019 Mar 20;36(2):103-109
pubmed: 29741621
Int J Emerg Med. 2009 Mar 11;2(2):121-2
pubmed: 20157455
J Adolesc Health. 2019 Mar;64(3):333-339
pubmed: 30409754
Chest. 2014 Apr;145(4):803-809
pubmed: 24158379
Heart. 2013 Feb;99(4):272-8
pubmed: 23257174
Nicotine Tob Res. 2005 Feb;7(1):149-56
pubmed: 15804687
Tob Control. 2017 Jan;26(1):92-97
pubmed: 27165994
Tob Control. 2015 Mar;24 Suppl 1:i60-i65
pubmed: 25550418
Pharmacol Biochem Behav. 2004 Sep;79(1):75-82
pubmed: 15388286
Addiction. 2018 Dec;113(12):2290-2299
pubmed: 30187978
Lancet Oncol. 2005 Dec;6(12):931-2
pubmed: 16353404
Am J Cardiol. 2018 Sep 1;122(5):905-909
pubmed: 30057235
Inhal Toxicol. 2016 Jul;28(8):339-42
pubmed: 27109645
Tob Control. 2015 Mar;24 Suppl 1:i44-i53
pubmed: 25492935
Tob Control. 2018 May;27(3):319-324
pubmed: 28381414
Ann Am Thorac Soc. 2019 Oct;16(10):1215-1219
pubmed: 31091965
Chest. 2014 Oct;146(4):924-931
pubmed: 24557573
Addict Behav. 2017 Nov;74:127-133
pubmed: 28624697
Lancet. 2000 Sep 30;356(9236):1175
pubmed: 11030308
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
Atherosclerosis. 2014 Jun;234(2):454-60
pubmed: 24814409
Inhal Toxicol. 2012 Aug;24(10):667-75
pubmed: 22906173
Chest. 2011 Nov;140(5):1378-1381
pubmed: 22045884
Addict Behav. 2018 Dec;87:131-137
pubmed: 30016762
BMC Public Health. 2011 Apr 19;11:244
pubmed: 21504559
Tob Induc Dis. 2020 Aug 25;18:69
pubmed: 32934615
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Ugeskr Laeger. 2006 Feb 27;168(9):904-7
pubmed: 16513054
East Mediterr Health J. 2020 Jan 30;26(1):18-28
pubmed: 32043542
Int J Epidemiol. 2010 Jun;39(3):834-57
pubmed: 20207606
Nicotine Tob Res. 2013 Dec;15(12):2069-75
pubmed: 23884320
Tob Control. 2015 Mar;24 Suppl 1:i3-i12
pubmed: 25298368
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105138
pubmed: 32912523
Int J Environ Res Public Health. 2015 May 29;12(6):6115-35
pubmed: 26110330
Respir Med. 2012 Dec;106 Suppl 2:S25-32
pubmed: 23290701
Lung India. 2014 Jul;31(3):237-43
pubmed: 25125810
Inhal Toxicol. 2017 Aug;29(10):429-434
pubmed: 29064301
Cochrane Database Syst Rev. 2015 Jul 31;(7):CD005549
pubmed: 26228266
Prev Med. 2015 Feb;71:88-93
pubmed: 25535678
Cardiovasc Hematol Agents Med Chem. 2019;17(2):82-93
pubmed: 31483237
Hepatology. 2001 Jan;33(1):248-53
pubmed: 11124843
Tob Control. 2015 Mar;24 Suppl 1:i22-i30
pubmed: 25666550
Chest. 2011 Apr;139(4):764-774
pubmed: 20671057
PLoS One. 2018 Feb 9;13(2):e0192191
pubmed: 29425207
ScientificWorldJournal. 2008 May 22;8:517-25
pubmed: 18516473
Int J Tuberc Lung Dis. 2003 Sep;7(9):860-5
pubmed: 12971670
Public Health. 2017 Jul;148:102-108
pubmed: 28458121
CJEM. 2012 Jan;14(1):57-9
pubmed: 22417961
Tob Control. 2006 Jun;15 Suppl 1:i24-9
pubmed: 16723671
East Mediterr Health J. 2012 Oct;18(10):996-1004
pubmed: 23301353
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
Int J Chron Obstruct Pulmon Dis. 2016 Jun 23;11:1391-401
pubmed: 27382275
Drug Alcohol Depend. 2011 Jul 1;116(1-3):102-9
pubmed: 21277706
Chest. 2011 Apr;139(4):775-781
pubmed: 21030492
PLoS One. 2014 Mar 24;9(3):e93097
pubmed: 24664109